Concordia Healthcare Corp. T.CXR.R

RE:Bill 72

[Craigbad]

I don't know if i would trust management on this colt, but its your money i guess. Here is a summary of times articles mentioning Amco in The Times investigation so i don't think they are under the radar, in fact they look like the main focus. 

• NHS failure on medicine prices costs public £125m

  Billy Kenber, Investigations Reporter

  Health staff queried the “large difference” in prices set by the British company AMCo — which has an effective monopoly over the supply of certain drugs — but merely asked for confirmation that the changes were correct. The new prices for 54 medicines alone cost the NHS an extra £125 million last year.

  Tuesday August 16 2016  |  The Times

• Alert on drug prices came two years ago 

  Billy Kenber, Investigations Reporter

  NHS officials in Manchester and Lincolnshire separately issued documents focusing on a large number of price rises in drugs marketed by one British firm, AMCo, now known as Concordia International.

  Tuesday August 16 2016  |  The Times

• Lessons in exploiting a loophole to make millions out of the NHS 

  Billy Kenber

  John Beighton, chief executive of the newly created AMCo, and his colleague Guy Clark set out their business model in a slideshow for delegates at a conference in November 2012.

  Saturday June 4 2016  |  The Times

• Firm’s £1.5bn drug profit is bitter pill for taxpayer

  Billy Kenber, Investigations Reporter

  In the past few years Cinven, which has headquarters in London, has bought up several of the main players, including Mercury Pharma Group, Amdipharm and Primegen Limited. It merged Mercury and Amdipharm into AMCo, before launching more takeovers.

  Saturday June 4 2016  |  The Times

• Drug firm plans to increase prices for older NHS drugs 

  Billy Kenber, Investigations Reporter

  The British chief executive of AMCo, which recently changed its name to Concordia International, told pharmaceutical industry analysts last month that the company had further price rises planned.

  Saturday September 3 2016  |  The Times

• Huge price rise forces NHS to ditch life-changing drug 

  Billy Kenber, Investigations Reporter

  Doctors have been encouraged to stop prescribing liothyronine 20mcg tablets by the NHS after AMCo, which enjoys a monopoly on the drug, implemented the price increase.

  Monday June 6 2016  |  The Times

• Cinven sells niche pharma group to rival

  Deirdre Hipwell

  Cinven has sold AMCo, its niche pharmaceuticals group, to a North America rival in a £2.3 billion deal as the merger and acquisition frenzy in the generic drug sector continues.

  Wednesday September 9 2015  |  The Times

• Price rise loophole was approved by Whitehall, drug company claimed

  Billy Kenber, Investigations Reporter

  Last week an investigation by this newspaper revealed how four companies made a fortune at taxpayers’ expense by buying the rights to old, off-patent drugs, dropping the brand name and increasing prices by up to 12,500 per cent. During a meeting with a US hedge fund last September John Beighton, the chief executive of AMCo, one of the four companies, is said to have explained how this method allowed it to implement price rises with “no restrictions” because generic drugs with no brand name were

  Tuesday June 7 2016  |  The Times

• Your five-minute digest

  1 NHS officials waved through medicine price rises of up to 600 per cent with no questions asked after demands from a monopoly supplier, according to emails seen by The Times. Health staff queried the “large difference” in new prices set for a host of drugs by the British company AMCo but merely asked for confirmation that the changes were correct.

  Tuesday August 16 2016  |  The Times

• How the loophole works

  Billy Kenber

  A small pharmaceutical company such as Atnahs or AMCo buys the rights to a drug’s brand name and its marketing authorisation.

  Friday June 3 2016  |  The Times

colt451 wrote: Only a complete idiot (i.e. a number of users on this board) would believe this bill matters. 

It was first read before the last CC, and management was asked point blank if NHS had approached them as one of the firms being targeted with the bill. Management answered no. Moreover Amaco does not engage in price hikes over 100% much less 1000% but instead 5-8% hikes.

If you want to continue to parade your stupidity around this board for longer go ahead Lettuce et al.